Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Magda Marečková, Nuffield Department of Women's & Reproductive Health DPhil student, has won this year's special prize, the Special Young Scientist Award at the Fast Forward Science 2020 web-video competition. She wins for her compelling video: "Heavy periods, sharp pain and no one to listen to you? Could you have Endometriosis?".

The web-video competition Fast Forward Science is a joint project of Wissenschaft im Dialog and the Stifterverband. It has been held annually since 2013. Prizes with a total value of € 21,500 will be awarded in 2020. The partner in the VISION category and of the Young Scientist Award is the Deutscher Zukunftspreis, the German President’s Award for Innovation in Science and Technology.

Fast Forward Science encourages students, communicators, researchers, web video makers and those interested in science to submit compelling web videos on scientific topics. The challenge: The videos should be entertaining, scientifically accurate and easy to understand at the same time. The aim is to make science web videos more visible. Web videos are an excellent way to communicate about scientific topics and are suitable for reaching large audiences. By enhancing their visibility and showcasing excellence, it will encourage more people to use them to communicate science.

Magda Marečková's wining video was awarded this year's Special Young Scientist Award. It shone a spotlight on Endometriosis  - a disease that is just as common as diabetes, but hardly anyone has heard of. Is there such a thing? It's a disease that affects 190 million women worldwide. This is associated with severe pain, but so far hardly researched. In her video, she explains what it is all about, the current state of research and how endometriosis is changing the lives of those affected.

Watch Magda's winning video here

The full story is available on the Nuffield Department of Women's & Reproductive Health website

 

Similar stories

Prestigious award for Oxford professor's diabetes work

A University of Oxford professor has been awarded the 2021 EASD-Novo Nordisk Foundation Prize for Excellence for his decades of effort to understand, prevent and combat type 1 diabetes.

Wellcome accolades for Dr Douglas

Dr Alexander (Sandy) Douglas, an investigator at the Jenner Institute, Nuffield Department of Medicine, has recently received two prestigious Wellcome accolades.

FOCUS4: a flagship trial in colorectal cancer

Professor Tim Maughan (Department of Oncology) outlines the flagship work of the FOCUS4 trials, whose results were presented last weekend at the European Society of Medical Oncology (ESMO) annual meeting

Oxford and Oracle partner to speed identification of COVID-19 variants

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.

Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool

Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalisation or death from 14 days post the second dose vaccination, when substantial immunity should be expected.